Search

Capricor Therapeutics Inc

Abierto

6.18 1.64

Resumen

Variación precio

24h

Actual

Mínimo

5.73

Máximo

6.29

Métricas clave

By Trading Economics

Ingresos

-6.8M

-41M

BPA

-0.7

Empleados

231

EBITDA

289M

255M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+342.62% upside

Dividendos

By Acuity

Próximas Ganancias

9 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

111M

334M

Apertura anterior

4.54

Cierre anterior

6.18

Capricor Therapeutics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

27 oct 2026, 23:56 UTC

Rithm Capital Corp. showed little change in after-market hours, trading lower since Tuesday's close, while remaining above its 20-day moving average.

27 oct 2026, 23:56 UTC

CDW Corporation shares declined in after-market trading, marking a third consecutive session of losses, despite broader market activity and rising durable goods orders in September.

27 oct 2026, 23:56 UTC

News

Rosenblatt downgraded OneSpan Inc. to Neutral while maintaining a price target of $18, contributing to a decline in after-market trading.

27 oct 2026, 23:56 UTC

Norwood Financial Corp's shares have declined in after-market trading, moving lower since Tuesday's close.

27 oct 2026, 23:56 UTC

NextDecade Corporation's shares traded roughly flat during after-market hours on Tuesday, initially showing a slight uptick before retracing to a modest gain.

27 oct 2026, 23:56 UTC

Waters Corp shares traded modestly lower in after-market hours, dipping nearly 1% below Tuesday's close before a slight recovery.

27 oct 2026, 23:56 UTC

Correlated Moves

Modine Manufacturing Company shares are modestly higher in after-market hours, coinciding with a significant rise in Ultra Clean Holdings following strong third-quarter results.

27 oct 2026, 23:56 UTC

Equinix, Inc. shares are modestly higher in after-market trading, continuing a trend of four consecutive sessions of gains amid rising durable goods orders.

27 oct 2026, 23:56 UTC

Lemonade Inc. traded modestly higher during after-market hours on Tuesday, increasing from a low point shortly after the regular session ended.

27 oct 2026, 23:52 UTC

Mexican Business Confidence Survey Set for Release Amid Ongoing Economic Challenges and Mixed Investor Sentiment

27 oct 2026, 23:52 UTC

Brazil's Central Bank faces pressure to maintain SELIC at 13.25% amid market fears of higher borrowing costs post-election, prompting downgrades in financial sector ratings.

27 oct 2026, 23:52 UTC

Australia's Building Permits MoM report on November 2, 2026, expected to reflect cautious market sentiment amid recent volatility and rising borrowing costs.

27 oct 2026, 23:52 UTC

South Korea's S&P Global Manufacturing PMI release on November 2 sparks cautious optimism amid mixed market sentiment and strong GDP growth.

27 oct 2026, 23:52 UTC

News

Morgan Stanley shares rose in after-market trading as the firm was named a lead underwriter for Anthropic's upcoming IPO, alongside Goldman Sachs.

27 oct 2026, 23:51 UTC

Lyft, Inc. shares are modestly higher in after-market trading, peaking before retracing slightly, while remaining above their 20-day moving average.

27 oct 2026, 23:51 UTC

ACCO Brands Corp is advancing in after-market trading, reflecting strength as it trades near the upper end of its one-month range.

27 oct 2026, 23:51 UTC

APTIV PLC shares are trading lower in after-market hours, declining to just below Tuesday's close and positioned below its 20-day moving average.

27 oct 2026, 23:51 UTC

Correlated Moves

Zillow Group, Inc. shares are lower in after-market trading following CoStar Group's $730 million acquisition of Vexcel and disappointing Q4 guidance.

27 oct 2026, 23:51 UTC

Oceaneering International Inc shares declined in after-market trading, continuing a trend from Tuesday's close, amid notable volatility below its 20-day moving average.

27 oct 2026, 23:51 UTC

Match Group, Inc. is rising in after-market trading, advancing significantly since Tuesday's close, despite having closed lower in the previous five sessions.

27 oct 2026, 23:51 UTC

Intuitive Surgical, Inc. shares declined modestly in after-market trading, reversing earlier gains and reflecting a cumulative loss.

27 oct 2026, 23:51 UTC

Correlated Moves
Social Media

AMD shares are modestly higher in after-market hours following its $1 billion investment in Meta's equity offering and deployment of AMD EPYC processors.

27 oct 2026, 23:51 UTC

Altria Group Inc. is trading modestly higher in after-market hours, rebounding after three consecutive sessions of declines while remaining above its 20-day moving average.

27 oct 2026, 23:51 UTC

Roku, Inc. declined during after-market trading, continuing a trend with four consecutive lower finishes since Tuesday's close.

27 oct 2026, 23:51 UTC

Coupang, Inc. is trading modestly lower in after-market hours, dipping below Tuesday's close and remaining significantly below its 20-day moving average.

27 oct 2026, 23:51 UTC

Correlated Moves

Vertiv Holdings Co is higher in after-market hours, following Ultra Clean Holdings Inc's third-quarter results that showed record revenue and earnings exceeding analyst expectations.

27 oct 2026, 23:51 UTC

GE HealthCare Technologies Inc. shares declined modestly in after-market trading, retreating from a brief peak earlier in the session.

27 oct 2026, 23:51 UTC

The Progressive Corporation is trading modestly higher in after-market hours, reaching its highest point since Tuesday's close and remaining above its 20-day moving average.

27 oct 2026, 23:51 UTC

Terex Corporation's shares are declining in after-market trading, reflecting continued weakness and trading well below its 20-day moving average.

27 oct 2026, 23:51 UTC

Wingstop Inc. is trading modestly lower in after-market hours, having shifted from a nearly flat position earlier in the session.

Comparación entre iguales

Cambio de precio

Capricor Therapeutics Inc previsión

Precio Objetivo

By TipRanks

342.62% repunte

Estimación a 12 Meses

Media 27 USD  342.62%

Máximo 54 USD

Mínimo 7 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Capricor Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

10 ratings

4

Comprar

6

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Capricor Therapeutics Inc

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment of duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs. The company's lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase 3 clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD). It also focused on developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases. In addition, the company develops CAP-2003, under pre-clinical development for the treatment of trauma related injuries and conditions. It has collaboration and distribution agreement with Nippon Shinyaku Co. Ltd., collaboration agreement with National Institute of Allergy and Infectious Diseases, license agreements with the Johns Hopkins University and Cedars-Sinai Medical Center, as well as cell line license agreement with Life Technologies Corporation. The company was founded in 2005 and is headquartered in San Diego, California.
help-icon Live chat